Investor Relations

Investor
Relations

Investor Communications

NorthStar Healthcare’s Q4 2023 Results and Business Update Conference Call
Date: Friday, March 29, 2024
Time: 4:00 p.m. ET | 1:00 p.m. PT
Dial in Number: 877-484-6065
Event Confirmation: #13744778

 

Investor Presentation - Internalization of Management

Investor Presentation NHI Internalization, October 2022

 

Frequently Asked Questions

Updated November 14, 2023

Click here to download the Frequently Asked Questions PDF

 

Supplemental Financial Reports 

Third Quarter 2023 Financial Supplement and Estimated Net Asset Value – 11.14.2023

Second Quarter 2023 Financial Supplement – 08.14.2023

First Quarter 2023 Financial Supplement – 05.10.2023

Click here for previous Supplemental Financial Reports

 

Shareholder Letters

Response to Comrit Tender Offer – 01.11.2024

June 30, 2023 Estimated Per Share Value – 11.14.2023

Response to Comrit Tender Offer – 03.10.2023

June 30, 2022 Estimated Per Share Value – 11.17.2022

Response to Comrit Tender Offer – 12.7.2022

Suspension of the Distribution Reinvestment Plan - 4.12.2022

June 30, 2021 Estimated Per Share Value – 11.18.2021

Response to Comrit Tender Offer - 4.27.2021

June 30, 2020 Estimated Per Share Value - 12.21.2020

Response to Comrit Tender Offer - 12.4.2020

Share Repurchase Program Suspension - 4.14.2020

June 30, 2019 Estimated Per Share Value - 12.11.2019

Response to Comrit Tender Offer - 12.11.2019

Monthly Distribution Suspension - 2.7.2019

Amended Share Repurchase Program - 10.15.2018

Response to MacKenzie Tender Offer - 8.13.2018